Analysts: Acceleron Pharma Inc (XLRN.O)

XLRN.O on Consolidated Issue listed on NASDAQ Global Market

28.91USD
29 Jul 2014
Price Change (% chg)

$0.16 (+0.56%)
Prev Close
$28.75
Open
$28.63
Day's High
$29.21
Day's Low
$28.45
Volume
121,725
Avg. Vol
288,746
52-wk High
$57.89
52-wk Low
$16.78

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.26 December 29 Jul 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.50 1.50 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 3 12.83 30.00 3.10 --
Quarter Ending Dec-14 3 11.33 20.90 0.00 --
Year Ending Dec-14 3 30.20 34.80 22.51 --
Year Ending Dec-15 2 10.20 20.40 0.00 --
Earnings (per share)
Quarter Ending Sep-14 4 -0.26 0.39 -0.54 --
Quarter Ending Dec-14 4 -0.22 0.05 -0.60 --
Year Ending Dec-14 4 -1.24 -1.01 -1.47 --
Year Ending Dec-15 4 -1.78 -1.12 -2.29 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-14 2.85 3.31 0.46 16.20
Quarter Ending Dec-13 13.66 11.52 2.14 15.64
Quarter Ending Sep-13 5.52 4.27 1.25 22.69
Earnings (per share)
Quarter Ending Mar-14 -0.44 -0.30 0.14 -31.82
Quarter Ending Dec-13 -0.08 -0.64 0.56 -753.33
Quarter Ending Sep-13 -0.40 -5.62 5.22 -1,305.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 12.83 12.83 12.83 12.83 --
Quarter Ending Dec-14 11.33 11.33 11.33 11.33 --
Year Ending Dec-14 30.20 30.20 30.20 30.20 --
Year Ending Dec-15 10.20 10.20 10.20 10.20 --
Earnings (per share)
Quarter Ending Sep-14 -0.26 -0.26 -0.26 -0.26 --
Quarter Ending Dec-14 -0.22 -0.22 -0.22 -0.22 --
Year Ending Dec-14 -1.24 -1.24 -1.24 -1.24 --
Year Ending Dec-15 -1.78 -1.78 -1.78 -1.78 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-14 0 0 0 0
Quarter Ending Dec-14 0 0 0 0
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 0 0 0
Earnings
Quarter Ending Sep-14 0 0 0 0
Quarter Ending Dec-14 0 0 0 0
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 0 0 0

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: GlobalData
$250.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks